{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:09:32Z","timestamp":1788307772368,"version":"build-2803163510"},"reference-count":32,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,10,1]]},"abstract":"<jats:sec><jats:title>Background.<\/jats:title><jats:p>A hypotonic\u2013hyporesponsive episode (HHE) is the sudden onset of hypotonia, hyporesponsiveness, and pallor or cyanosis that occurs within 48 hours after childhood immunizations. This syndrome has been primarily associated with pertussis-containing vaccines administered to children &amp;lt;2 years of age, and has been estimated to occur once every 1750 diphtheria-tetanus-pertussis (DTwP) vaccinations. Previous studies of HHE were limited by small numbers of cases and, sometimes, by limited details of the event.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives.<\/jats:title><jats:p>To characterize a large number of HHE cases reported to the Vaccine Adverse Event Reporting System (VAERS), to assist clinicians in identifying HHE, and to assist researchers in investigating the risk factors, cause, and pathogenesis of this syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>More than 40\u2009000 VAERS reports received between 1996 and 1998 were screened for HHE by a computer algorithm and reviewed, and a telephone follow-up questionnaire was administered to the witness of HHE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>There were 215 HHE cases, all nonfatal. The median age of onset of HHE was 4.0 months (range: 1.1\u2013107 months). Over half of the reports (53%) concerned females. The median birth weight was 3.36 kg (range: 1.27\u20134.96 kg); 4.7% had a birth weight &amp;lt;2500 g. The median interval between vaccination and HHE was 210 minutes (range: 1 minute\u20132 days). Among children with HHE who were &amp;lt;24 months of age, the episode occurred within 5 minutes in only 8.5%, compared with 66.7% of children with HHE &amp;gt;24 months of age. There were no relevant findings regarding family medical history or the mothers' gestational history.<\/jats:p><jats:p>Nearly all of the children (98.6%) returned to their prevaccination state according to the telephone questionnaire; median time to return was 6 hours (range: 1 minute\u2013 4 months). The 3 children reported as not returning to their prevaccination state all had VAERS reports submitted after they developed conditions (autism, complex partial epilepsy, and developmental delays with infantile spasms) that are not known to be causally associated with immunization.<\/jats:p><jats:p>The vast majority of children (93%) with HHE received a pertussis-containing vaccine, either diphtheria-tetanus-acellular pertussis (DTaP, 28%), DTwP (11%), or diphtheria-tetanus-pertussis-Haemophilus influenzae type b (DTwP-HIB, 61%). During the HHE episode, 90.1% of the children had pallor and 49% had cyanosis. Because of the HHE event, 6.8% of children had had all vaccines withheld as of the date of the interview. Of the remainder, 66.5% of children have had 1 or more subsequent vaccinations or vaccine components withheld, and 26.7% have not had any subsequent vaccinations withheld. Only 1 child was reported to have had a repeat episode of HHE, occurring after hepatitis B vaccination. From 1996 to 1998, the number of HHE reports decreased from 99 to 38, when the predominant pertussis vaccine administered to infants changed from whole-cell to acellular.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>This study represents the largest published case series of children with HHE and supports the generally benign, self-limited, nonrecurrent nature of this syndrome. Although HHE has been less frequently reported to VAERS after increased use of DTaP, HHE does occur after the administration of DTaP and other nonpertussis-containing vaccines. Although most parents and pediatricians withheld the pertussis component of subsequent vaccinations, many did not, with no reported adverse events occurring in the children after the subsequent immunizations. Restricting the definition of HHE to a more narrow age range (eg, &amp;lt;2 years of age) is also proposed because most of the older children probably experienced vasovagal syncope rather than HHE within 5 minutes of immunization.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.106.4.e52","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:50:41Z","timestamp":1092441041000},"page":"e52-e52","source":"Crossref","is-referenced-by-count":63,"title":["Hypotonic\u2013Hyporesponsive Episodes Reported to the Vaccine Adverse Event Reporting System (VAERS), 1996\u20131998"],"prefix":"10.1542","volume":"106","author":[{"given":"Tracy S.","family":"DuVernoy","sequence":"first","affiliation":[{"name":"1 From the Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Miles","family":"Braun","sequence":"additional","affiliation":[{"name":"1 From the Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the VAERS Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2000,10,1]]},"reference":[{"key":"2021121009285992400_B1","first-page":"241","article-title":"Illness after whooping cough vaccination.","volume":"106","author":"Hopper","year":"1961","journal-title":"Med Officer"},{"key":"2021121009285992400_B2"},{"key":"2021121009285992400_B3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1542\/peds.68.5.650","article-title":"Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children.","volume":"68","author":"Cody","year":"1981","journal-title":"Pediatrics"},{"key":"2021121009285992400_B4","first-page":"101","article-title":"Hypotonic hyporesponsive episodes in eight pertussis vaccine studies.","volume":"89","author":"Heijbel","year":"1997","journal-title":"Dev Biol Stand (Basel)"},{"key":"2021121009285992400_B5","first-page":"789","article-title":"Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation.","volume":"81","author":"Baraff","year":"1988","journal-title":"Pediatrics"},{"key":"2021121009285992400_B6","first-page":"73","article-title":"Hypotonic-hyporesponsive episodes in children hospitalized at 10 Canadian pediatric tertiary-care centres, 1991\u20131994.","volume":"23","author":"Gold","year":"1997","journal-title":"Can Comm Dis Rep"},{"key":"2021121009285992400_B7","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1542\/peds.91.6.1158","article-title":"Severe reactions associated with diphtheria-tetanus-pertussis vaccine: detailed studies of children with seizures, hypotonic-hyporesponsive episodes, high fevers, and persistent crying.","volume":"91","author":"Blumberg","year":"1993","journal-title":"Pediatrics"},{"key":"2021121009285992400_B8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0264-410X(94)90315-8","article-title":"The Vaccine Adverse Event Reporting System (VAERS).","volume":"12","author":"Chen","year":"1994","journal-title":"Vaccine"},{"key":"2021121009285992400_B9"},{"key":"2021121009285992400_B10"},{"key":"2021121009285992400_B11","first-page":"829","article-title":"Notice to readers: national vaccination coverage levels among children aged 19\u201335 months\u2014United States, 1998.","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021121009285992400_B12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.96.3.557","article-title":"Comparison of 13 acellular pertussis vaccines: adverse reactions.","volume":"96","author":"Decker","year":"1995","journal-title":"Pediatrics"},{"key":"2021121009285992400_B13"},{"key":"2021121009285992400_B14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1542\/peds.96.3.592","article-title":"Association of reactions after consecutive acellular or whole-cell pertussis vaccine immunizations.","volume":"96","author":"Deloria","year":"1995","journal-title":"Pediatrics"},{"key":"2021121009285992400_B15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0022-3476(05)80727-9","article-title":"Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants.","volume":"119","author":"Blumberg","year":"1991","journal-title":"J Pediatr"},{"key":"2021121009285992400_B16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archpedi.1996.02170300011001","article-title":"The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine: a postmarketing assessment.","volume":"150","author":"Rosenthal","year":"1996","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2021121009285992400_B17"},{"key":"2021121009285992400_B18"},{"key":"2021121009285992400_B19","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/bmj.316.7135.902","article-title":"Rate of recurrent collapse after vaccination with whole cell pertussis vaccine: follow up study.","volume":"316","author":"Vermeer-deBondt PE, Labadie J, Ru\u0308mke HC","year":"1998","journal-title":"Br Med J"},{"key":"2021121009285992400_B20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1440-1754.1999.00419.x","article-title":"Vaccination of children following a previous hypotonic-hyporesponsive episode.","volume":"35","author":"Goodwin","year":"1999","journal-title":"J Paediatr Child Health"},{"key":"2021121009285992400_B21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0022-3476(83)80278-9","article-title":"Seizures following childhood immunizations.","volume":"102","author":"Hirtz","year":"1983","journal-title":"J Pediatr"},{"key":"2021121009285992400_B22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0022-3476(85)80134-7","article-title":"History of convulsions and use of pertussis vaccine.","volume":"107","author":"Prensky","year":"1985","journal-title":"J Pediatr"},{"key":"2021121009285992400_B23","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0022-3476(05)80640-7","article-title":"Pertussis vaccine and injury to the brain.","volume":"116","author":"Golden","year":"1990","journal-title":"J Pediatr"},{"key":"2021121009285992400_B24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0022-3476(88)80004-0","article-title":"Relationship of pertussis immunization to the onset of neurologic disorders: a retrospective epidemiologic study.","volume":"113","author":"Shields","year":"1988","journal-title":"J Pediatr"},{"key":"2021121009285992400_B25","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJM199806113382403","article-title":"Long-term intellectual and behavioral outcomes of children with febrile convulsions.","volume":"338","author":"Verity","year":"1998","journal-title":"N Engl J Med"},{"key":"2021121009285992400_B26","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0022-3476(09)90014-2","article-title":"Pertussis immunization and characteristics related to first seizures in infants and children.","volume":"122","author":"Cherry","year":"1993","journal-title":"J Pediatr"},{"key":"2021121009285992400_B27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1542\/peds.81.3.345","article-title":"Neurologic events following diphtheria-tetanus-pertussis immunization.","volume":"81","author":"Walker","year":"1988","journal-title":"Pediatrics"},{"key":"2021121009285992400_B28","first-page":"287","article-title":"Diphtheria-tetanus-pertussis vaccine and serious neurologic illness: an updated review of the epidemiologic evidence.","volume":"87","author":"Wentz","year":"1991","journal-title":"Pediatrics"},{"key":"2021121009285992400_B29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archpedi.1997.02170400041007","article-title":"Syncope after immunization.","volume":"151","author":"Braun","year":"1997","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2021121009285992400_B30","doi-asserted-by":"crossref","first-page":"850","DOI":"10.7326\/0003-4819-112-11-850","article-title":"Syncope: current diagnostic evaluation and management.","volume":"112","author":"Manolis","year":"1990","journal-title":"Ann Intern Med"},{"key":"2021121009285992400_B31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/jnnp.38.6.613","article-title":"Prevalence of migraine.","volume":"38","author":"Waters","year":"1975","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2021121009285992400_B32","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2105\/AJPH.85.12.1706","article-title":"The reporting sensitivities of two passive surveillance systems for vaccine adverse events.","volume":"85","author":"Rosenthal","year":"1995","journal-title":"Am J Public Health"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/106\/4\/e52\/843209\/e52.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/106\/4\/e52\/843209\/e52.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T07:34:47Z","timestamp":1734507287000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/106\/4\/e52\/65833\/Hypotonic-Hyporesponsive-Episodes-Reported-to-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10,1]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2000,10,1]]},"published-print":{"date-parts":[[2000,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.106.4.e52","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[2000,10,1]]}}}